Product Information
VYVANSE 60 MG CHEWABLE TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.3689 per EA under NDC 59417012001. Its NADAC has been published 197 times since Sep 21, 2022.
The High Outlier badge above means this manufacturer's average price in the LISDEXAMFETAMINE DIMESYLATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
59417012001
Classification
Brand
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA208510On Market Since
1/28/2017
Pharmacological Classes
Price Statistics
The NADAC for VYVANSE 60 MG CHEWABLE TABLET has been published 197 times since Sep 21, 2022, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3689 per EA |
|---|---|
| All-time high | $12.4079 (Nov 13, 2024) |
| All-time low | $11.3047 (Sep 21, 2022) |
| 52-week high | $12.3861 |
| 52-week low | $12.3531 |
| Median price | $12.3542 |
| Average price | $12.1465 |
| Largest weekly change | +5.0% (Jan 3, 2024) |
| Weeks tracked | 197 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VYVANSE 60 MG CHEWABLE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VYVANSE 60 MG CHEWABLE TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.3689 per EA (NDC 59417012001), effective Jun 24, 2026.
How has the price of VYVANSE 60 MG CHEWABLE TABLET changed over time?
Over the history we have for it, the NADAC for VYVANSE 60 MG CHEWABLE TABLET has risen 9.4%. It has been tracked across 197 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for VYVANSE 60 MG CHEWABLE TABLET?
Since Sep 21, 2022, the NADAC for VYVANSE 60 MG CHEWABLE TABLET has ranged from a low of $11.3047 (Sep 21, 2022) to a high of $12.4079 (Nov 13, 2024), with a median of $12.3542 per EA.
Are there cheaper alternatives to VYVANSE 60 MG CHEWABLE TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LISDEXAMFETAMINE 60 MG CAPSULE, is $2.9745 per EA — about 76% below VYVANSE 60 MG CHEWABLE TABLET.
Who manufactures VYVANSE 60 MG CHEWABLE TABLET?
VYVANSE 60 MG CHEWABLE TABLET (NDC 59417012001) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification